Infection of macaques with a molecular clone, SHIVSF33A2, provides evidence for tissue specific variants

• Published in: Journal of medical primatology Vol. 31; no. 4-5; pp. 164 - 170
• Main Authors: Buckner, C M, Gettie, A, Tan, R C H, Eshetu, T, Ratterree, M, Blanchard, J, Cheng-Mayer, C, Harouse, J M
• Format: Journal Article
• Language: English
• Published: Denmark 01-08-2002
• Subjects: Animals; Disease Models, Animal; DNA, Recombinant - genetics; DNA, Viral - analysis; DNA, Viral - genetics; Evolution, Molecular; Genetic Variation - genetics; Heteroduplex Analysis; HIV - genetics; HIV - physiology; HIV Infections - virology; Lymphoid Tissue - virology; Macaca mulatta - virology; Mutation - genetics; Organ Specificity; Simian Acquired Immunodeficiency Syndrome - virology; Simian Immunodeficiency Virus - genetics; Simian Immunodeficiency Virus - physiology; Time Factors; Viremia - virology
• ISSN: 0047-2565; 1600-0684
• DOI: 10.1034/j.1600-0684.2002.d01-63.x

Infection of rhesus macaques with chimeric simian-human immunodeficiency viruses (SHIV) is an established model to study acquired immunodeficiency syndrome (AIDS) pathogenesis. Such a controlled system allows for detailed analysis of the molecular determinants of viral pathogenesis in addition to studying host-specific immune responses that modulate disease progression. Furthermore, the use of a pathogenic molecular clone affords the opportunity to study both viral evolution within a host and to examine the generation of tissue specific variants. In this report we describe viral diversification within tissues of two rhesus macaques infected intravenously with the CXCR4-specific molecular clone SHIVSF33A2. Heteroduplex tracking analysis (HTA) was used to determine the complexity of viral DNA within distinct lymphoid tissues. Not surprising, heterogeneity of the proviral quasispecies in tissues obtained during the acute infection was limited. However, tissues obtained at necropsy harbored a more diverse and often different population of env variants. As the inoculating virus is a molecular clone, the variants generated are likely due to the presence of tissue specific selective forces rather than a founder's effect.